???pagination.result.count???
???pagination.result.page???
1
Sulfonylureas suppress the stimulatory action of Mg-nucleotides on Kir6.2/ SUR1 but not Kir6.2/ SUR2A KATP channels: a mechanistic study. , Proks P., J Gen Physiol. November 1, 2014; 144 (5): 469-86.
Recessive mutations in PCBD1 cause a new type of early-onset diabetes. , Simaite D., Diabetes. October 1, 2014; 63 (10): 3557-64.
Purinergic receptor-induced Ca2+ signaling in the neuroepithelium of the vomeronasal organ of larval Xenopus laevis. , Dittrich K., Purinergic Signal. January 1, 2014; 10 (2): 327-36.
Molecular mechanism of sulphonylurea block of K(ATP) channels carrying mutations that impair ATP inhibition and cause neonatal diabetes. , Proks P., Diabetes. November 1, 2013; 62 (11): 3909-19.
Mutations of the same conserved glutamate residue in NBD2 of the sulfonylurea receptor 1 subunit of the KATP channel can result in either hyperinsulinism or neonatal diabetes. , Männikkö R., Diabetes. June 1, 2011; 60 (6): 1813-22.
Relapsing diabetes can result from moderately activating mutations in KCNJ11. , Gloyn AL., Hum Mol Genet. April 1, 2005; 14 (7): 925-34.
Inhibition of recombinant K(ATP) channels by the antidiabetic agents midaglizole, LY397364 and LY389382. , Proks P., Eur J Pharmacol. September 27, 2002; 452 (1): 11-9.
The novel diazoxide analog 3-isopropylamino-7-methoxy-4H-1,2,4-benzothiadiazine 1,1-dioxide is a selective Kir6.2/ SUR1 channel opener. , Dabrowski M., Diabetes. June 1, 2002; 51 (6): 1896-906.
Glimepiride block of cloned beta-cell, cardiac and smooth muscle K(ATP) channels. , Song DK., Br J Pharmacol. May 1, 2001; 133 (1): 193-9.
Effects of mitiglinide (S 21403) on Kir6.2/ SUR1, Kir6.2/ SUR2A and Kir6.2/SUR2B types of ATP-sensitive potassium channel. , Reimann F., Br J Pharmacol. April 1, 2001; 132 (7): 1542-8.
The antimalarial agent mefloquine inhibits ATP-sensitive K-channels. , Gribble FM., Br J Pharmacol. October 1, 2000; 131 (4): 756-60.
Sensitivity of Kir6.2- SUR1 currents, in the absence and presence of sodium azide, to the K(ATP) channel inhibitors, ciclazindol and englitazone. , McKay NG., Br J Pharmacol. June 1, 2000; 130 (4): 857-66.
Expression of Xenopus snail in mesoderm and prospective neural fold ectoderm. , Essex LJ., Dev Dyn. October 1, 1993; 198 (2): 108-22.